• Home
  •  / Verseau Therapeutics

Verseau Therapeutics

OverviewSuggest Edit

Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases. Its modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.
TypePrivate
Founded2017
HQBedford, USMap
Websiteverseautx.com
View Jobs

Locations

Verseau Therapeutics is headquartered in
Bedford, United States

Location Map
All Locations (1)

Latest Updates

Employees (est.) (Feb 2020)25

Key People/Management at Verseau Therapeutics

Christine Bunt

Christine Bunt

Chief Executive Officer
Robert Crane

Robert Crane

MBA Chief Financial Officer
Igor Feldman

Igor Feldman

Co-Founder and Head of Computational Biology
Tatiana Novobrantseva

Tatiana Novobrantseva

Co-Founder and Chief Scientific Officer
George Golumbeski

George Golumbeski

Chairman of the Board, Verseau
Tim Smith

Tim Smith

Chief Business Officer
Show more

Verseau Therapeutics Office Locations

Verseau Therapeutics has an office in Bedford
Bedford, US (HQ)
47 Wiggins Ave
Show all (1)

Verseau Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2017

Verseau Therapeutics total Funding

$50 m

Verseau Therapeutics latest funding size

$50 m

Time since last funding

4 months ago

Verseau Therapeutics investors

20/20 HealthCare Partners, Highlight Capital, Alexandria Venture Investments, Yonghua Capital, 3sbio, InHarv Partners, The Mark Foundation for Cancer Research
Verseau Therapeutics's latest funding round in October 2019 was reported to be $50 m. In total, Verseau Therapeutics has raised $50 m
Show all financial metrics

Verseau Therapeutics Online and Social Media Presence

Verseau Therapeutics's Trends

Embed Graph

 Verseau Therapeutics Frequently Asked Questions

  • When was Verseau Therapeutics founded?

    Verseau Therapeutics was founded in 2017.

  • Who are Verseau Therapeutics key executives?

    Verseau Therapeutics's key executives are Christine Bunt, Robert Crane and Igor Feldman.

  • How many employees does Verseau Therapeutics have?

    Verseau Therapeutics has 25 employees.

  • Who are Verseau Therapeutics competitors?

    Competitors of Verseau Therapeutics include Werewolf Therapeutics, Intrepida Bio and MaxiVAX.

  • Where is Verseau Therapeutics headquarters?

    Verseau Therapeutics headquarters is located at 47 Wiggins Ave, Bedford.

  • Where are Verseau Therapeutics offices?

    Verseau Therapeutics has an office in Bedford.

  • How many offices does Verseau Therapeutics have?

    Verseau Therapeutics has 1 office.